Business Wire

Premia Spine’s TOPS™ Facet Replacement Demonstrates Significant Improvement in All Patient-Reported Outcome Measures in FDA Trial

NORWALK, Conn.--(BUSINESS WIRE)--Premia Spine, a medical technology company changing the way debilitating chronic leg and back pain is treated, today announced publication of two-year outcomes from ...
The Victoria Advocate

Premia Spine Announces First TOPS™ System Surgery Following FDA Approval

The first U.S. surgery with FDA-approved TOPS™ System, led by Jared D. Ament, MD, a board-certified and fellowship-trained neurosurgeon. The TOPS™ System is an innovative solution designed to treat ...
Yahoo Finance

Spinal Cord Stimulation Devices Market Outlook Report, 2025-2033: Revenues Set to Surge, Reaching $6.73 Billion by 2033

Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Spinal Cord Stimulation Devices Global Market Report by Product, Application, End User, Countries and Company Analysis, 2025-2033" has been added to ...